Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN studIeS for TreatMent of Acute Myocardial Infarction: MECHANISM-AMI
Phase of Trial: Phase IV
Latest Information Update: 26 Mar 2019
Price : $35 *
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery restenosis; Myocardial infarction; Stent thrombosis
- Focus Therapeutic Use
- Acronyms MECHANISM-AMI
- 17 Mar 2019 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 26 May 2016 Bare metal stent has been removed from the study hence, study title, study design (randomized to non randomised and interventional to observational), inclusion criteria and treatment (Vascular responses are evaluated at 2 weeks or 3 months OCT follow-up) changed.